Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

708
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
708
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

500
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
500
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

307
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
307
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

382
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
382
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

507
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
507
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

642
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
642

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Infection of the lower urinary tract: new possibilities of herbal medicine].

Urologiia (Moscow, Russia : 1999)·2022
Same author

[Antiadhesive strategy for non-antibacterial prophylaxis of recurrent lower urinary tract infections].

Urologiia (Moscow, Russia : 1999)·2021
Same author

[Recurrent lower urinary tract infection in women: treatment and prevention].

Urologiia (Moscow, Russia : 1999)·2020
Same author

[D-mannose for prevention and treatment of lower urinary tract infection: pathogenetic basics and clinical results].

Urologiia (Moscow, Russia : 1999)·2020
Same author

[Efficiency and safety of phenazopyridine for treatment of uncomplicated urinary tract infection: results of multi-center, randomized, placebo-controlled, clinical study].

Urologiia (Moscow, Russia : 1999)·2020
Same author

[Fosfomycin for treatment of uncomplicated lower urinary tract infection].

Urologiia (Moscow, Russia : 1999)·2018

Related Experiment Video

Updated: Mar 7, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

3.0K

[Litholytic therapy for urate nephrolithiasis].

S Kh Al'-Shukri1,2, M N Slesarevskaya2, I V Kuz'min1,2

  • 1Department of Urology First Pavlov State Medical University of St. Peterburg.

Urologiia (Moscow, Russia : 1999)
|March 2, 2017
PubMed
Summary
This summary is machine-generated.

Pre-treatment with litholytic therapy (Blemaren) significantly enhances extracorporeal shock wave lithotripsy (ESWL) effectiveness for uric acid kidney stones, improving stone disintegration and density reduction.

Keywords:
Blemarencitrate therapykidney stonelitholysisurate nephrolithiasis

More Related Videos

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

8.3K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K

Related Experiment Videos

Last Updated: Mar 7, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

3.0K
Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

8.3K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K

Area of Science:

  • Urology
  • Nephrology
  • Medical Chemistry

Background:

  • Uric acid kidney stones (urate nephrolithiasis) pose a significant clinical challenge.
  • Extracorporeal shock wave lithotripsy (ESWL) is a common treatment modality.
  • Optimizing ESWL outcomes for uric acid stones requires further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of ESWL combined with litholytic therapy for uric acid kidney stones.
  • To determine if pre-treatment with litholytic agents improves ESWL outcomes.
  • To assess the impact on stone size, density, and disintegration rates.

Main Methods:

  • A prospective study involving 59 patients with urate nephrolithiasis.
  • Patients were divided into two groups: study group (litholytic therapy before ESWL) and control group (ESWL only).
  • Litholytic therapy (Blemaren) administered for 4 weeks prior to ESWL in the study group.

Main Results:

  • The study group showed a 60% decrease in calculus size and an 83.3% decrease in calculus density after 4 weeks of Blemaren.
  • Stone disintegration after a single ESWL session was higher in the study group (86.7%) compared to the control group (65.5%).
  • Pre-treatment with Blemaren demonstrated a clear benefit in preparing uric acid stones for ESWL.

Conclusions:

  • A 4-week course of Blemaren is recommended to treat patients with urate nephrolithiasis prior to ESWL.
  • This combined approach enhances treatment efficacy for uric acid kidney stones.
  • Pre-treatment optimizes stone characteristics for successful lithotripsy.